** Shares in herbal medicines and hemp products maker
TYHT.O hit highest level since June 2018, last up ~38% at
$16.47
** Shineco proposes to buy at least 51% equity interest in
Taiwan-based biotech Mayah Biological
** Co says there is no guarantee, however, that the parties
to the proposal will enter into a definitive agreement
urn:newsml:reuters.com:*:nGNX6HvVVP
** Mayah Biological focuses on the development of chemical
and biomedicine in the pre-clinical and clinical stages
** TYHT shares have jumped more than three-fold YTD
(Reporting by Arundhati Sarkar in Bengaluru)
((Arundhati.Sarkar@thomsonreuters.com;
twitter.com/Arundhati_05; +1 646 223 8780 Ext: 2776))